<DOC>
	<DOCNO>NCT01669811</DOCNO>
	<brief_summary>This phase 3 multicentre , randomise , double-blind , parallel-group , comparative study evaluate efficacy esomeprazole ( D961H ) 20 mg twice daily esomeprazole ( D961H ) 20 mg daily patient ( form esomeprazole magnesium salt ) refractory reflux esophagitis 8 week standard Proton-pump inhibitor ( PPI ) therapy assessment presence/absence inflammation ( esophagitis ) Week 8 accord Los Angeles ( LA ) classification</brief_summary>
	<brief_title>Compare D961H 20 mg Bid 20 mg qd Patients With Refractory Reflux Esophagitis ( Inflammation Lower Esophagus )</brief_title>
	<detailed_description>A multicentre , randomise , double-blind , parallel-group , comparative study compare efficacy safety D961H 20 mg twice daily oral administration D961H 20 mg daily oral administration patient refractory reflux esophagitis</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>1 . Provision inform consent prior study specific procedure . 2 . Patients RE classify LA classification Grade A , B , C D Endoscopy despite least 8week treatment use standard dos PPIs . 3 . Patients must fulfill least one follow criterion ( ) RE LA grade C/D Endoscopy visit 1 and/or history RE LA grade C/D , ( ii ) RE diagnose 1 year visit 1 . 4 . Patients able complete Patient Diary 1 . Male female age less 20 year time inform consent . 2 . Patients current evidence gastrointestinal diseases/conditions esophageal stricture interfere evaluation study etc 3 . Gastric duodenal ulcer verify Endoscopy within 12 week randomisation . 4 . Previous esophageal , gastric duodenal surgery except simple closure perforate ulcer , simple endoscopic treatment simple operation etc 5 . Current historical evidence ( within 12 week prior randomisation ) diseases/conditions judge interfere evaluation study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Refractory Reflux Esophagitis ,</keyword>
	<keyword>Japanese ,</keyword>
	<keyword>Nexium ,</keyword>
	<keyword>twice daily ,</keyword>
	<keyword>oral administration</keyword>
</DOC>